Skip links

Ultradoll-8

Dollvet Veteriner Aşıları

Ultradoll-8

INACTIVE COMBINED CLOSTRIDIAL VACCINE


INACTIVE COMBINED CLOSTRIDIAL VACCINE

Ultradoll-8 Prospectus

1200px-PDF_file_icon.svg

ULTRADOLL-8
Pharmaceutical Formulation: Injectable Suspension

It is an inactive bacterin toxoid vaccine used for protection in ruminants (cattle, calf, sheep, lamb, goat and kid) against blackleg disease caused by Clostridium chauvoei, bacillary icterohemoglobinuria caused by Clostridium haemolyticum, malignant edema and bradzot caused by Clostridium septicum, gangrenous emphysema (myonecrosis) and infectious necrotic hepatitis caused by Clostridium novyi, tetanus caused by Clostridium tetani, lamb dysentery, enterotoxemia, hemorrhagic enterotoxemia, struck and pulpey kidney disease infections caused by Clostridium perfringens type B, C and D.

Sheep/lamb, goat/kid, cattle/calf

COMPOSITION:Each dose of vaccine (2 ml) contains following:

Components Amount
Clostridium perfringens β toxoid ≥10 IU/ml*
Clostridium perfringens ε toxoid ≥5 IU/ml*
Cl. novyi α toxoid ≥3,5 IU/ml**
Cl. septicum α toxoid ≥2,5 IU/ml*
Cl. chauvoei master culture ≥90% protection***
Cl. haemolyticum master culture ≥75% protection***
Cl. tetani toxoid ≥2,5 IU/ml*
Al(OH)3adjuvant 0,2 ml
80% unit of phenol 0,0064 ml
37% unit of formaldehyde 0,008 ml

* * Amount of antitoxin in rabbit blood serum that is vaccinated with 1 dose
** ** Amount of antitoxin in guinea pig blood serum that is vaccinated with 1 dose

****** Epruvation result in guinea pig that is vaccinated with 1 dose

It is an inactive bacterin toxoid vaccine used for protection in ruminants (cattle, calf, sheep, lamb, goat and kid) against blackleg disease caused by Clostridium chauvoei, bacillary icterohemoglobinuria caused by Clostridium haemolyticum, malignant edema and bradzot caused by Clostridium septicum, gangrenous emphysema (myonecrosis) and infectious necrotic hepatitis caused by Clostridium novyi, tetanus caused by Clostridium tetani, lamb dysentery, enterotoxemia, hemorrhagic enterotoxemia, struck and pulpey kidney disease infections caused by Clostridium perfringens type B, C and D.

Annual periodic vaccination is performed in sheep and goats with 2 ml, in lamb and kids with 1 ml, in cattle with 4 ml and in calves with 2 ml. Animals vaccinated fort he first time should be revaccinated 21 days after the first vaccination (Sheep and goats: 2 ml, lamb and kids: 1 ml, cattle: 4 ml, calves: 2 ml). The vaccine from the second month is applied to all ages of sheep, goats, lambs and kids by intramuscularly or subcutaneously to armpit, hairless and immobile area, to cattle and calves by intramuscularly or subcutaneously to immobile area of the back of the shoulder.

Keep at + 2/8ºC and in a dark place. Shelf life is 2 years. Do not freeze.

Withdrawal period for animal origin products is 0 days.

Vaccine is marketed in 20, 50, and 100 ml amber type II glass vials or 20, 50, 100, 200, 250 and 500 ml plastic vials 10, 25, 50, 100, 125 and 250 sheep, goat and calf dose; 5, 12, 25, 50, 62, and 125 bovine dose and 20, 50, 100, 200, 250, and 500 lambs. Not all packaging forms may be available. Each bottle is closed with a butyl stopper and aluminium lid and marketed in boxes containing 50 or 100 styrofoam vials containing the package insert up to number of bottles. The package does not contain any diluents.